Literature DB >> 2408967

Tear histamine during allergic conjunctivitis challenge.

O Kari, O P Salo, L Halmepuro, K Suvilehto.   

Abstract

Tear histamine was measured in 14 patients with allergic conjunctivitis during a challenge test performed at a symptom-free point in time. The allergen challenge caused a rapid increase in the amount of tear histamine in only two-thirds of the patients, but there was a clinical reaction in all. The increase in the tear histamine content occurred in both the challenged and contralateral non-challenged eye, and the increase was also equally high in both. It is probable that the histamine release in the challenged eye takes place in the conjunctiva, whereas in the contralateral eye it is possibly induced by some sympathetic mechanism in the lacrimal gland.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408967     DOI: 10.1007/bf02150945

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  6 in total

1.  Tear histamine levels in vernal conjunctivitis and other ocular inflammations.

Authors:  M B Abelson; R S Baird; M R Allansmith
Journal:  Ophthalmology       Date:  1980-08       Impact factor: 12.079

2.  Measurement of plasma histamine: description of an improved method and normal values.

Authors:  J Dyer; K Warren; S Merlin; D D Metcalfe; M Kaliner
Journal:  J Allergy Clin Immunol       Date:  1982-08       Impact factor: 10.793

3.  Cold urticaria. Dissociation of cold-evoked histamine release and urticara following cold challenge.

Authors:  T M Keahey; M W Greaves
Journal:  Arch Dermatol       Date:  1980-02

4.  Histamine in human tears.

Authors:  M B Abelson; N A Soter; M A Simon; J Dohlman; M R Allansmith
Journal:  Am J Ophthalmol       Date:  1977-03       Impact factor: 5.258

5.  A novel double-isotope technique for the enzymatic assay of plasma histamine: application to estimation of mast cell activation assessed by antigen challenge in asthmatics.

Authors:  M J Brown; P W Ind; R Causon; T H Lee
Journal:  J Allergy Clin Immunol       Date:  1982-01       Impact factor: 10.793

6.  Arterial plasma histamine levels at rest, and during and after exercise in patients with asthma: effects of terbutaline aerosol.

Authors:  S D Anderson; P T Bye; R E Schoeffel; J P Seale; K M Taylor; L Ferris
Journal:  Thorax       Date:  1981-04       Impact factor: 9.139

  6 in total
  8 in total

Review 1.  Allergic ocular disease. A review of pathophysiology and clinical presentations.

Authors:  L Bielory; P E Goodman; E M Fisher
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

Review 2.  Diagnostics and new developments in the treatment of ocular allergies.

Authors:  Osmo Kari; K Matti Saari
Journal:  Curr Allergy Asthma Rep       Date:  2012-06       Impact factor: 4.806

Review 3.  Antihistamines in ocular allergy: are they all created equal?

Authors:  Mark B Abelson; James T McLaughlin; Paul J Gomes
Journal:  Curr Allergy Asthma Rep       Date:  2011-06       Impact factor: 4.806

4.  Rapid appearance of plasmin in tear fluid after ocular allergen exposure.

Authors:  E M Salonen; J Lauharanta; P S Sim; R Stephens; A Vaheri
Journal:  Clin Exp Immunol       Date:  1988-07       Impact factor: 4.330

Review 5.  The central role of conjunctival mast cells in the pathogenesis of ocular allergy.

Authors:  Andrea Leonardi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

6.  Updates in the treatment of ocular allergies.

Authors:  Osmo Kari; K Matti Saari
Journal:  J Asthma Allergy       Date:  2010-11-24

7.  Treatment of allergic conjunctivitis with bepotastine besilate ophthalmic solution 1.5%.

Authors:  Mark T Bergmann; Jon I Williams; Paul J Gomes
Journal:  Clin Ophthalmol       Date:  2014-08-13

8.  Mediator profiles in tears during the conjunctival response induced by allergic reaction in the nasal mucosa.

Authors:  Zdenek Pelikan
Journal:  Mol Vis       Date:  2013-07-12       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.